A detailed history of Black Rock Inc. transactions in Zomedica Corp. stock. As of the latest transaction made, Black Rock Inc. holds 9,862,981 shares of ZOM stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,862,981
Previous 9,862,981 -0.0%
Holding current value
$1.18 Million
Previous $1.48 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.12 - $0.19 $63,320 - $100,257
-527,669 Reduced 5.08%
9,862,981 $1.48 Million
Q3 2023

Nov 13, 2023

SELL
$0.16 - $0.23 $179,259 - $257,686
-1,120,374 Reduced 9.73%
10,390,650 $1.77 Million
Q2 2023

Aug 11, 2023

BUY
$0.19 - $0.22 $240,194 - $278,120
1,264,183 Added 12.34%
11,511,024 $2.3 Million
Q1 2023

May 12, 2023

SELL
$0.16 - $0.29 $168,455 - $305,326
-1,052,849 Reduced 9.32%
10,246,841 $2.15 Million
Q4 2022

Feb 13, 2023

SELL
$0.16 - $0.25 $3,374 - $5,272
-21,090 Reduced 0.19%
11,299,690 $1.81 Million
Q3 2022

Nov 14, 2022

SELL
$0.2 - $0.38 $6,543 - $12,432
-32,718 Reduced 0.29%
11,320,780 $2.39 Million
Q2 2022

Aug 12, 2022

SELL
$0.2 - $0.34 $412,960 - $702,032
-2,064,801 Reduced 15.39%
11,353,498 $2.5 Million
Q1 2022

May 12, 2022

BUY
$0.28 - $0.4 $198,238 - $283,197
707,993 Added 5.57%
13,418,299 $4.52 Million
Q4 2021

Feb 10, 2022

SELL
$0.31 - $0.58 $1.68 Million - $3.13 Million
-5,403,693 Reduced 29.83%
12,710,306 $3.9 Million
Q3 2021

Nov 09, 2021

BUY
$0.46 - $0.81 $362,762 - $638,778
788,615 Added 4.55%
18,113,999 $9.48 Million
Q2 2021

Aug 11, 2021

BUY
$0.72 - $1.46 $12.5 Million - $25.3 Million
17,325,384 New
17,325,384 $14.4 Million

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $118M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.